Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Bost

Showing results (91-100 of 155) with videos related to

Pageof 16
Sort By:
Cellular Immunology|September 15, 1981
Anti-IgD enhancement of primary antibody responses in ratsM A Cuchens, K L Bost, M L Hoover, et al.
Clinical Reviews in Allergy & Immunology|December 22, 1999
Immunotherapy for food allergies. Past, present, futureS B Lehrer, L G Wild, K L Bost, et al.
Infectious Agents and Cancer|September 6, 2012
An expanded myeloid derived suppressor cell population does not play a role in gammaherpesvirus-exacerbated breast cancer metastasesDaniel A Nelson, Vinita S Chauhan, Melanie D Tolbert, et al.
The Journal of Rheumatology|August 1, 1992
Mechanisms of pathogenesis in scleroderma. I. Overproduction of interleukin 6 by fibroblasts cultured from affected skin sites of patients with sclerodermaC A Feghali, K L Bost, D W Boulware, et al.
Journal of Neuroimmunology|September 29, 2007
Expression of neuronal trace amine-associated receptor (Taar) mRNAs in leukocytesDaniel A Nelson, Melanie D Tolbert, Sam J Singh, et al.
Brain Research|March 20, 1999
Transmission routes of HIV-1 gp120 from brain to lymphoid tissuesM F Cashion, W A Banks, K L Bost, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2004
Substance P augments Borrelia burgdorferi-induced prostaglandin E2 production by murine microgliaAmy Rasley, Ian Marriott, Craig R Halberstadt, et al.
Immunology|April 1, 1996
In vivo treatment with anti-interleukin-13 antibodies significantly reduces the humoral immune response against an oral immunogen in miceK L Bost, R H Holton, T K Cain, et al.
Methods in Enzymology|January 1, 1989
Use of peptides encoded by complementary RNA for generating anti-idiotypic antibodies of predefined specificityJ E Blalock, J N Whitaker, E N Benveniste, et al.
Agents and Actions|February 1, 1987
Changes in the DNA of lymphocytes from pristane treated ratsL R Garrett, K L Bost, T M Buttke, et al.
Pageof 16

Showing results (91-100 of 155) with videos related to

Sort By:
Pageof 16
Cellular Immunology|September 15, 1981
Anti-IgD enhancement of primary antibody responses in ratsM A Cuchens, K L Bost, M L Hoover, et al.
Clinical Reviews in Allergy & Immunology|December 22, 1999
Immunotherapy for food allergies. Past, present, futureS B Lehrer, L G Wild, K L Bost, et al.
Infectious Agents and Cancer|September 6, 2012
An expanded myeloid derived suppressor cell population does not play a role in gammaherpesvirus-exacerbated breast cancer metastasesDaniel A Nelson, Vinita S Chauhan, Melanie D Tolbert, et al.
The Journal of Rheumatology|August 1, 1992
Mechanisms of pathogenesis in scleroderma. I. Overproduction of interleukin 6 by fibroblasts cultured from affected skin sites of patients with sclerodermaC A Feghali, K L Bost, D W Boulware, et al.
Journal of Neuroimmunology|September 29, 2007
Expression of neuronal trace amine-associated receptor (Taar) mRNAs in leukocytesDaniel A Nelson, Melanie D Tolbert, Sam J Singh, et al.
Brain Research|March 20, 1999
Transmission routes of HIV-1 gp120 from brain to lymphoid tissuesM F Cashion, W A Banks, K L Bost, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2004
Substance P augments Borrelia burgdorferi-induced prostaglandin E2 production by murine microgliaAmy Rasley, Ian Marriott, Craig R Halberstadt, et al.
Immunology|April 1, 1996
In vivo treatment with anti-interleukin-13 antibodies significantly reduces the humoral immune response against an oral immunogen in miceK L Bost, R H Holton, T K Cain, et al.
Methods in Enzymology|January 1, 1989
Use of peptides encoded by complementary RNA for generating anti-idiotypic antibodies of predefined specificityJ E Blalock, J N Whitaker, E N Benveniste, et al.
Agents and Actions|February 1, 1987
Changes in the DNA of lymphocytes from pristane treated ratsL R Garrett, K L Bost, T M Buttke, et al.
Pageof 16